Errol B Desouza's Net Worth
$6.33 Million
Who is Errol B Desouza?
Errol B Desouza has an estimated net worth of $6.33 Million. This is based on reported shares across multiple companies, which include Royalty Pharma plc, Biodel Inc, CATALYST BIOSCIENCES, INC., Cyclerion Therapeutics, Inc., IDEXX LABORATORIES INC /DE, and PALATIN TECHNOLOGIES INC.
SEC CIK
Errol B Desouza's CIK is 0001213895
Past Insider Trading and Trends
2007 was Errol B Desouza's most active year for acquiring shares with 11 total transactions. Errol B Desouza's most active month to acquire stocks was the month of May. 2012 was Errol B Desouza's most active year for disposing of shares, totalling 5 transactions. Errol B Desouza's most active month to dispose stocks was the month of August. 2008 saw Errol B Desouza paying a total of $262,093.45 for 202,279 shares, this is the most they've acquired in one year. In 2012 Errol B Desouza cashed out on 200,261 shares for a total of $108,905.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Royalty Pharma plc (RPRX) Snapshot price: $29.325
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.42% | 9.29K |
—
|
—
| 73.74K |
Jun 7
| |||
Form 4
| +13.66% | 7.75K |
—
|
—
| 64.44K |
Jun 23
| |||
Form 4
| +12.56% | 6.33K |
—
|
—
| 56.7K |
Jun 24
| |||
Form 4
| +12.83% | 5.73K |
—
|
—
| 50.37K |
Jun 25
| |||
Form 4
| +25.00% | 8.93K |
—
|
—
| 44.64K |
Jun 15 - Jun 18
| |||
Form 4
|
∞
| 35.72K |
—
|
—
| 35.72K |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biodel Inc No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +122.16% | 87.66K |
$0.44 | -$19,126.36 | 159.42K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
| +5.69% | 3.87K |
—
|
—
| 71.76K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
| +17.27% | 10K |
$3.34 | $33,400.00 | 67.89K |
Sep 20
| |||
Form 4
| +7.11% | 3.84K |
—
|
—
| 57.89K |
Mar 12 - Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
| +222.23% | 37.28K |
$2.87 | -$54,452.51 | 54.05K |
Sep 30
| |||
Form 4
| +222.23% | 37.28K |
$2.87 | -$54,452.51 | 54.05K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
| +203.65% | 45K |
—
|
—
| 67.1K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 23
| |||
Form 4
| +124.49% | 12.25K |
$0.61 | $7,474.94 | 22.1K |
Nov 9
| |||
Form 4
|
∞
| 9.84K |
—
|
—
| 9.84K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CATALYST BIOSCIENCES, INC. (GYRE) Snapshot price: $11.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.69% | 3.59K |
—
|
—
| 29.8K |
Oct 1
| |||
Form 4
| +14.93% | 3.41K |
—
|
—
| 26.21K |
Jun 9 - Jul 1
| |||
Form 4
| +14.72% | 2.93K |
—
|
—
| 22.81K |
Apr 1
| |||
Form 4
| +11.99% | 2.13K |
—
|
—
| 19.88K |
Jan 5
| |||
Form 4
| +21.36% | 3.13K |
—
|
—
| 17.75K |
Oct 1
| |||
Form 4
| +17.03% | 2.13K |
—
|
—
| 14.63K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +29.67% | 2.86K |
—
|
—
| 12.5K |
Apr 1
| |||
Form 4
| +23.52% | 1.83K |
—
|
—
| 9.64K |
Jan 2
| |||
Form 4
| +48.40% | 2.54K |
—
|
—
| 7.8K |
Oct 1
| |||
Form 4
| +52.49% | 1.81K |
—
|
—
| 5.26K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +77.37% | 1.5K |
—
|
—
| 3.45K |
Apr 1
| |||
Form 4
| +706.64% | 1.7K |
—
|
—
| 1.94K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
| +187.51% | 10K |
—
|
—
| 15.33K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
| +166.65% | 3.33K |
$0.08 | $249.98 | 5.33K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| +100.00% | 1K |
$0.08 | $75.00 | 2K |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyclerion Therapeutics, Inc. (CYCN) Snapshot price: $2.726
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +166.67% | 50K |
—
|
—
| 80K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDEXX LABORATORIES INC /DE (IDXX) Snapshot price: $571.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.57% | 318 |
$39.30 | $12,497.40 | 7.28K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +5.79% | 381 |
$32.80 | $12,496.80 | 6.96K |
Jan 30
| |||
Form 4
| +5.72% | 356 |
$35.16 | $12,516.96 | 6.58K |
Oct 30
| |||
Form 4
| +4.00% | 239 |
$52.21 | $12,478.19 | 6.22K |
Jul 30
| |||
Form 4
| +4.09% | 235 |
$53.20 | $12,502.00 | 5.98K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +4.07% | 225 |
$55.62 | $12,514.50 | 5.75K |
Jan 30
| |||
Form 4
| +3.33% | 89 |
$117.84 | $10,487.76 | 2.76K |
Oct 30
| |||
Form 4
| +4.13% | 106 |
$99.46 | $10,542.76 | 2.67K |
Jul 30
| |||
Form 4
| +4.73% | 116 |
$90.17 | $10,459.72 | 2.57K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +4.70% | 110 |
$84.15 | $9,256.50 | 2.45K |
Jan 30
| |||
Form 4
| +4.84% | 108 |
$85.49 | $9,232.92 | 2.34K |
Oct 30
| |||
Form 4
| +5.04% | 107 |
$86.81 | $9,288.67 | 2.23K |
Jul 28
| |||
Form 4
| +5.51% | 111 |
$83.21 | $9,236.31 | 2.13K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +9.52% | 175 |
$77.21 | $13,511.75 | 2.01K |
Jan 30
| |||
Form 4
| +7.80% | 133 |
$68.51 | $9,111.83 | 1.84K |
Oct 28
| |||
Form 4
| +9.22% | 144 |
$63.46 | $9,138.24 | 1.71K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +12.86% | 178 |
$56.74 | $10,099.72 | 1.56K |
Apr 29
| |||
Form 4
| +17.79% | 209 |
$58.01 | $12,124.09 | 1.38K |
Jan 31
| |||
Form 4
| +18.57% | 184 |
$49.84 | $9,170.56 | 1.18K |
Oct 29
| |||
Form 4
| +22.35% | 181 |
$50.39 | $9,120.59 | 991 |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +22.54% | 149 |
$56.87 | $8,473.63 | 810 |
Mar 31
| |||
Form 4
| +44.96% | 205 |
$46.28 | $9,487.40 | 661 |
Dec 31
| |||
Form 4
| +96.55% | 224 |
$42.55 | $9,531.20 | 456 |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||